ProfileGDS4718 / 203708_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 58% 60% 76% 57% 57% 72% 72% 58% 77% 60% 60% 78% 70% 63% 80% 85% 72% 66% 90% 92% 53% 62% 60% 67% 72% 66% 56% 69% 60% 49% 94% 66% 68% 60% 61% 75% 54% 75% 77% 88% 67% 63% 80% 65% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.993158
GSM549102patient 115, normal, homogenized [OPG study]6.1368660
GSM549104patient 119, normal, homogenized [OPG study]7.5205676
GSM549108patient 138, normal, homogenized [OPG study]5.962757
GSM549119patient 077, normal, homogenized [OPG study]5.9180157
GSM549133patient 032, cancer, homogenized [OPG study]7.0982172
GSM549139patient 042, cancer, homogenized [OPG study]7.0940272
GSM549099patient 107, normal, homogenized [OPG study]5.9717458
GSM549109patient 139, normal, homogenized [OPG study]7.4661977
GSM549110patient 046, normal, homogenized [OPG study]6.1307760
GSM549114patient 063, normal, homogenized [OPG study]6.0456360
GSM549122patient 082, normal, homogenized [OPG study]7.6578378
GSM549134patient 033, cancer, homogenized [OPG study]6.876170
GSM549136patient 036, cancer, homogenized [OPG study]6.3597163
GSM549140patient 044, cancer, homogenized [OPG study]7.9317680
GSM549111patient 047, normal, homogenized [OPG study]8.4839285
GSM549113patient 057, normal, homogenized [OPG study]7.0822972
GSM549132patient 031, cancer, homogenized [OPG study]6.5854466
GSM549137patient 038, cancer, homogenized [OPG study]9.2149590
GSM549142patient 047, cancer, homogenized [OPG study]9.0511292
GSM549100patient 110, normal, homogenized [OPG study]5.7096253
GSM549107patient 135, normal, homogenized [OPG study]6.2211162
GSM549115patient 068, normal, homogenized [OPG study]6.0979160
GSM549116patient 072, normal, homogenized [OPG study]6.662167
GSM549120patient 078, normal, homogenized [OPG study]7.0501172
GSM549131patient 030, cancer, homogenized [OPG study]6.6077566
GSM549118patient 074, normal, homogenized [OPG study]5.8611756
GSM549129patient 027, cancer, homogenized [OPG study]6.8271669
GSM549123patient 088, normal, homogenized [OPG study]6.1194460
GSM549124patient 006, cancer, homogenized [OPG study]5.5031949
GSM549126patient 015, cancer, homogenized [OPG study]9.7966894
GSM549128patient 025, cancer, homogenized [OPG study]6.6449266
GSM549103patient 117, normal, homogenized [OPG study]6.662168
GSM549117patient 073, normal, homogenized [OPG study]6.0835460
GSM549138patient 041, cancer, homogenized [OPG study]6.2070361
GSM549141patient 045, cancer, homogenized [OPG study]7.483675
GSM549130patient 028, cancer, homogenized [OPG study]5.7510654
GSM549101patient 111, normal, homogenized [OPG study]7.2748575
GSM549105patient 128, normal, homogenized [OPG study]7.4737277
GSM549106patient 134, normal, homogenized [OPG study]9.0476288
GSM549112patient 048, normal, homogenized [OPG study]6.6186367
GSM549125patient 011, cancer, homogenized [OPG study]6.3354763
GSM549127patient 024, cancer, homogenized [OPG study]7.8847180
GSM549135patient 035, cancer, homogenized [OPG study]6.5092565